Group A Streptococcal Meningitis With the M1UK Variant in the Netherlands

Boas C L van der Putten; Bart J M Vlaminckx; Brechje de Gier; Wieke Freudenburg-de Graaf; Nina M van Sorge

doi:10.1001/jama.2023.5927

Group A Streptococcal Meningitis With the M1UK Variant in the Netherlands

JAMA. 2023 May 23;329(20):1791-1792. doi: 10.1001/jama.2023.5927.

Authors

Boas C L van der Putten¹, Bart J M Vlaminckx², Brechje de Gier¹, Wieke Freudenburg-de Graaf³, Nina M van Sorge³

Affiliations

¹ Epidemiology and Surveillance of Infectious Diseases, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
² Department of Medical Microbiology and Immunology, St Antonius Hospital, Nieuwegein, the Netherlands.
³ Department of Medical Microbiology and Infection Prevention, Amsterdam UMCs, Amsterdam, the Netherlands.

No abstract available

Plain language summary

This study reports an epidemiological assessment of laboratory-confirmed group A streptococcal meningitis cases in the Netherlands using more than 40 years of national bacteriological surveillance data.

MeSH terms

Humans
Meningitis, Bacterial* / epidemiology
Meningitis, Bacterial* / genetics
Meningitis, Bacterial* / microbiology
Netherlands / epidemiology
Streptococcal Infections* / epidemiology
Streptococcal Infections* / genetics
Streptococcal Infections* / microbiology
Streptococcus agalactiae
Streptococcus pyogenes* / genetics